Vanguard's Growth ETF Usually Beats the Market After a Lagging Year. I'd Own It, but Not for a 2027 Rebound.

The Vanguard Morningstar Growth ETF is up about 7% in 2026, trailing the S&P 500’s roughly 11% gain; six of its 10 largest holdings have lagged the index, and the fund has fallen about 6% since its Oct. 6 record close. Its concentrated exposure to large technology stocks, AI-spending concerns, elevated inflation and higher interest rates have weighed on performance. The fund has beaten the S&P 500 in 16 of 21 calendar years since 2005, but the article cautions that this history does not reliably predict a rebound; its end-September P/E was 32.1 versus 24.7 for Vanguard’s S&P 500 ETF.

Analysis

The useful signal is not the historical rebound rate; it is that a concentrated growth basket is being repriced against both higher discount rates and uncertainty over AI returns. A narrow group of mega-cap positions can amplify further earnings or valuation disappointments, while broad-market exposure may benefit if leadership broadens. Conversely, a sustained decline in real yields or clear evidence that AI spending is converting into revenue and earnings could quickly reverse the relative move, given the same concentration.

Near term, monitor Treasury yields, inflation releases, and revisions to forward earnings and capital-spending guidance at the largest holdings. Over 1–3 months, weak guidance or continued multiple compression could extend VUG’s relative lag; the key missing evidence is whether earnings estimates are actually being cut, rather than sentiment alone. Over 6–18 months, realized AI monetization versus investment is the fundamental test. The historical “bounce after a lag year” is not a reliable catalyst: the sample is small and growth’s generally high win rate makes the conditional result uninformative. No basis here to call the long-term growth premium cheap or expensive beyond the reported valuation gap.

Key Decisions for Investors

• Consider a modest, defined-risk relative underweight in VUG versus SPY while rate and AI-return uncertainty remain elevated; avoid treating the year-to-date lag itself as a buy signal. Reassess after major inflation data and the next round of mega-cap guidance.
• Falsify the relative-underweight thesis if real yields fall materially and large-cap growth earnings revisions stabilize or improve; that combination could restore growth leadership and make a short-VUG leg costly.
• Do not initiate single-name shorts in NVDA, TSLA, AVGO, or other holdings on this evidence alone. Track earnings revisions, AI-related spending and disclosed returns, and fund concentration before adding directional exposure.
• For a long-horizon allocation, scale in rather than timing a one-year mean reversion; verify valuation and forward-earnings changes first. A further deterioration in guidance or a renewed rise in yields would argue for delaying additions.